Premium
ORAL HYOSCINE BUTYLBROMIDE DOES NOT ALTER THE PATTERN OF SMALL INTESTINAL MOTOR ACTIVITY
Author(s) -
THOMPSON D.G.,
WINGATE D.L.
Publication year - 1981
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/j.1476-5381.1981.tb09149.x
Subject(s) - motor activity , scopolamine , medicine , chemistry , neuroscience , anesthesia , psychology
1 Continuous recording of proximal jejunal motility in conscious healthy subjects was made following ingestion of 200 mg hyoscine butylbromide (ten times the recommended therapeutic dosage). 2 There was no detectable modification of fasting or postprandial motor activity, although the therapeutic potency of the standard intravenous dose was confirmed.